Mark Attarian

Mark Attarian is an accomplished executive with extensive experience in financial and operational advisory roles across various industries, particularly in healthcare, technology, and manufacturing. As the Chief Executive Officer of Attarian, LLC since January 2016, Attarian has provided financial and operational insights to middle-market companies. In addition, Attarian serves as an Independent Board Member for Tobacco Technology, Inc./eLiquiTech, Inc. and has held significant financial leadership roles, including Chief Financial Officer positions at PharmaLogic Holdings Corp., IntegraMed Fertility, and Track Group, Inc. Attarian also acted as Interim Chief Financial Officer for EnterpriseDB Corporation and has a proven track record in guiding organizations through critical initiatives at firms such as Tatum and Molecular Insight Pharmaceuticals. Education includes a Bachelor of Arts from St. Lawrence University and a high school diploma from The Albany Academies.